Psychiatric Institute of Washington — Washington D.C., District of Columbia

Psychiatric Institute of Washington is a clinical research site located in Washington D.C., District of Columbia, United States 20016.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Psychiatric Institute of Washington has participated in 2 clinical trials.

Therapeutic areas: Schizophrenia.

Sponsors: Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Psychiatric Institute of Washington?

Psychiatric Institute of Washington has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Psychiatric Institute of Washington conducted?

Psychiatric Institute of Washington has 2 clinical trials on record. Their work covers Schizophrenia.

Is Psychiatric Institute of Washington accredited by Crixeo Health?

Psychiatric Institute of Washington has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Psychiatric Institute of Washington?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.